Peter Bui
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
-
- Glutathione Transferases and Polymorphisms 2
- Epigenetics and DNA Methylation 1
- Co-authors
- Oliver Hankinson (9 shared papers)Sudheer Beedanagari (3 shared papers)Erin L. Hsu (1 shared paper)Satoshi Imaizumi (1 shared paper)Srinivasa T. Reddy (1 shared paper)Derek W. Nickerson (1 shared paper)Robert T. Taylor (1 shared paper)Parrisa Solaimani (2 shared papers)
- Journals
- Molecular Pharmacology (3 papers)Drug Metabolism and Disposition (2 papers)Toxicology Letters (1 paper)Toxicology and Applied Pharmacology (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- United StatesPolandItaly
In The Last Decade
Peter Bui
14 papers receiving 539 citations
Peers
Comparison fields: 5 of 67
- Pharmacology 145
- Biochemistry 83
- Geriatrics and Gerontology 25
- Cancer Research 90
- Oncology 104
Countries citing papers authored by Peter Bui
This map shows the geographic impact of Peter Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bui more than expected).
Fields of papers citing papers by Peter Bui
This network shows the impact of papers produced by Peter Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bui. The network helps show where Peter Bui may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 118 | |
| 2 | PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. | 2013 | 90 |
| 3 | 2010 | 72 | |
| 4 | 2010 | 61 | |
| 5 | 2009 | 46 | |
| 6 | 2009 | 43 | |
| 7 | 2011 | 35 | |
| 8 | 2008 | 27 | |
| 9 | 2011 | 17 | |
| 10 | 2013 | 15 | |
| 11 | 2011 | 12 | |
| 12 | 2024 | 5 | |
| 13 | Continuous Vasopressin Infusion for the Management of Central Diabetes Insipidus | 2017 | 2 |
| 14 | 2013 | 1 |
About Peter Bui
Peter Bui is a scholar working on Pharmacology, Molecular Biology, Biochemistry, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 544 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Genomic variations and chromosomal abnormalities (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper), Epigenetics and DNA Methylation (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Pharmacology (145 citations), Biochemistry (83 citations), Geriatrics and Gerontology (25 citations), Cancer Research (90 citations) and Oncology (104 citations). Peter Bui has collaborated with scholars based in United States, Poland and Italy. Frequent co-authors include Oliver Hankinson, Sudheer Beedanagari, Erin L. Hsu, Satoshi Imaizumi, Srinivasa T. Reddy, Derek W. Nickerson, Robert T. Taylor, Parrisa Solaimani, Feng Wang and Arnulfo Quesada. Their work appears in journals such as Molecular Pharmacology, Drug Metabolism and Disposition, Toxicology Letters, Toxicology and Applied Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.